Tagged in :
You May Love
-
SAPHNELO approved in the US for subcutaneous self-administration for treatment of systemic lupus erythematosus (SLE)
.
The U.S. Food & Drug Administration (FDA) has granted approval for subcutaneous administration of anifrolumab (SAPHNELO) for treatment of people living with moderately to severely active autoantibody-positive systemic lupus…
-

New World Lupus Federation Global Survey Finds 58% Know Very Little or Nothing About Lupus
.
Low familiarity and ongoing misconceptions underscore the need for increased education and broader visibility, building on more than a decade of…

Leave a Reply